For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
Yon-Lian Wu |
Yon-Lian Wu |
Yon-Lian Wu |
03-4809168 |
No.255,Longyuan 1st Rd.,Longtan Dist.,Taoyuan City32542,Taiwan(R.O.C) |
2022/01/19 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
Sunny Pharmtech Inc. (Sunny) is a unique integrated specialty pharmaceutical company.Through integration of the research teams, facilities, and core technology platforms, Sunny aims to be capable of developing API and specialty chemicals, various dosage forms of drug products with strong distribution partners in the US.The generic product candidates Sunny picked are mostly essential drugs with technology hurdles and niche market.Sunny has dedicated teams to develop APIs which are difficult to synthesize or unable to source.The formulation teams are capable of developing various dosage forms such as extended release oral liquid and solid, semi-solid, and injectable with a strong analytical support and pilot plant as well. In addition to generic arena, Sunny also played a role in 505(b)2 new drug development with intellectual property protection. |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|